Citation: | LI Xiaoluan, WANG Ye, CHEN Cheng. Efficacy of continuous positive airway pressure combined with medicine in treatment of type 2 diabetes mellitus patients with obstructive sleep apnea hypopnea syndrome[J]. Journal of Clinical Medicine in Practice, 2022, 26(22): 52-55, 59. DOI: 10.7619/jcmp.20222391 |
To observe the clinical efficacy of continuous positive airway pressure (CPAP) combined with montelukast and liraglutide in the treatment of type 2 diabetes mellitus (T2DM) patients with obstructive sleep apnea-hypopnea syndrome (OSAHS).
A total of 123 T2DM patients complicating OSAHS were randomly divided into control group (n=62) and observation group (n=61). The control group was orally taken montelukast sodium and percutaneous injection of liraglutide, and the observation group received CPAP on the basis of the control group. The serum levels of 8-iso-prostaglandin F2α (8-iso-PGF2α), interleukin-6 (IL-6), CXC-chemokine ligand 13 (CXCL13), sleep breathing parameters, cognitive ability, sleep quality and OSAHS severity were observed and compared between the two groups before and after treatment.
After treatment, the apnea hypopnea index (AHI), longest apnea time and lowest pulse volume oxygen saturation in the observation group were (10.41±2.58) times/h, (41.07±5.69) s and (88.09±6.58)%, respectively, which were lower, shorter or higher than (14.29±2.62) times/h, (50.98±3.15) s and (72.36± 4.26)%, respectively of the control group (P < 0.05). After treatment, the serum levels of 8-iso-PGF2α, IL-6 and CXCL13 in the observation group were (103.57±23.58), (20.54±4.21) and (68.29±14.59) pg/mL, respectively, which were lower than (245.29±15.36), (26.38±3.01) and (92.47±10.22) pg/mL, respectively, in the control group (P < 0.05). After treatment, OSAHS severity in the observation group was lower than that in the control group (P < 0.05). After treatment, the cognitive ability scored (23.61±3.29) in the observation group, which was higher than (20.87±1.16) in the control group, and sleep quality scored (0.38±0.08) in the observation group, which was lower than (1.42±0.22) in the control group (P < 0.05).
CPAP combined with montelukast sodium and liraglutide can significantly reduce serum levels of 8-iso-PGF2α, IL-6 and CXCL13, improve sleep quality, relieve disease severity and promote recovery of cognitive function in T2DM patients with OSAHS.
[1] |
曹思佩, 王洪眉, 吴峰. 夜间脉搏血氧饱和度对阻塞性睡眠呼吸暂停低通气综合征伴2型糖尿病患者的预测价值[J]. 实用临床医药杂志, 2022, 26(5): 75-78, 85. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202205017.htm
|
[2] |
陈文武, 王鑫, 饶文明, 等. 痰热清注射液对AECOPD肺部感染合并T2DM疗效机制及巨噬细胞异质性途径干预作用探讨[J]. 中国医院药学杂志, 2019, 39(12): 1282-1286. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYZ201912016.htm
|
[3] |
范榕, 白亚丽, 赵雅宁, 等. 血清CTRP3、SLOX-1水平与OSAHS合并T2DM患者下肢血管病变的关系研究[J]. 重庆医学, 2019, 48(14): 2377-2380, 2385. doi: 10.3969/j.issn.1671-8348.2019.14.010
|
[4] |
刘淬平, 秦露丹, 徐勇, 等. 2型固有淋巴细胞在糖尿病肾脏疾病发病机制中作用的研究[J]. 中国糖尿病杂志, 2020, 28(12): 926-932. doi: 10.3969/j.issn.1006-6187.2020.12.009
|
[5] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38(4): 292-344. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201804009.htm
|
[6] |
阻塞性睡眠呼吸暂停低通气综合征诊治指南(基层版)写作组. 阻塞性睡眠呼吸暂停低通气综合征诊治指南(基层版)[J]. 中华全科医师杂志, 2015, 14(7): 509-515. doi: 10.3760/cma.j.issn.1671-7368.2015.07.007
|
[7] |
董志爽, 李光源, 刘文, 等. 脉搏波传导速度评价阻塞性睡眠呼吸暂停低通气综合征患者动脉僵硬度的研究进展[J]. 实用临床医药杂志, 2022, 26(5): 135-138. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202205030.htm
|
[8] |
ARRIOLA-VILLALOBOS P, BENITO-PASCUAL B, PERAZA-NIEVES J, et al. Corneal topographic, anatomic, and biomechanical properties in severe obstructive sleep apnea-hypopnea syndrome[J]. Cornea, 2020, 39(1): 88-91. doi: 10.1097/ICO.0000000000002102
|
[9] |
段燕燕, 薛孟周, 朱宁. 伴有阻塞性睡眠呼吸暂停低通气综合征的脑梗死患者血清同型半胱氨酸和胱抑素C水平变化及其对认知功能的影响[J]. 实用临床医药杂志, 2021, 25(17): 43-47. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202117009.htm
|
[10] |
中华医学会糖尿病学分会, 中华医学会内分泌学分会. 中国成人2型糖尿病合并心肾疾病患者降糖药物临床应用专家共识[J]. 中华糖尿病杂志, 2020, 12(6): 369-381.
|
[11] |
DONG M, GUO F, ZHOU T, et al. Association of diabetic nephropathy with the severity of obstructive sleep apnea-hypopnea syndrome in patients with type 2 diabetes mellitus[J]. Endocr J, 2020, 67(5): 515-522.
|
[12] |
LEPARA O, ZACIRAGIC A, FAJKIC A, et al. Peripheral 8-iso-PGF2αas a biomarker in bosnian patients with Alzheimer's Disease and vascular dementia[J]. Psychiatr Danub, 2020, 32(3-4): 389-394.
|
[13] |
王婷, 杨璐, 胡凤蓉, 等. 短期胰岛素泵治疗老年T2DM对患者血清hs-CRP、EL、8-iso-PGF2α水平的影响[J]. 海南医学, 2021, 32(7): 843-846. https://www.cnki.com.cn/Article/CJFDTOTAL-HAIN202107007.htm
|
[14] |
郭建梅, 赵季红. 慢性心力衰竭合并阻塞性睡眠呼吸暂停低通气综合征患者经鼻持续气道正压通气治疗效果分析[J]. 中国医药, 2019, 14(2): 204-207. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG201902012.htm
|
[15] |
孙雪婷, 孙志丹, 冯艳红. 超声极速脉搏波技术评估中重度阻塞性睡眠呼吸暂停患者CPAP治疗前后颈动脉弹性的变化[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(8): 707-711. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202108008.htm
|